Radiology Personnel

Xiaoming Yang, M.D., Ph.D.

Director, Image-Guided Bio-Molecular Interventions Research
Interventional Radiology


Dr. Yang is a UW professor and director of image-guided bio-molecular interventions research in the Department of Radiology at the University of Washington School of Medicine. He is also an attending physician of interventional radiology at UW Medical Center, and holds an appointment as a senior lecturer of radiology at Kuopio University in Finland and as an attending physician of radiology qualified in European community countries.
Dr. Yang received his M.D. in 1983 from Suzhou University School of Medicine, China. He then received a master’s degree of medical science in 1986 from the Chinese Academy of Medical Sciences and Peking Union Medical University in Beijing, followed by a Ph.D. of medical science in 1991 from Kuopio University, Finland.
Dr. Yang completed his residencies in radiology at Peking Union Hospital in Beijing and Kuopio University Hospital in Finland, followed by post-doctoral fellowships at Johns Hopkins University and the University of Washington. In 2002, Dr. Yang was appointed associate professor and co-director of the Center for Image-Guided Interventions at Johns Hopkins University School of Medicine.
Because of his special background of both a physician and a scientist, Dr. Yang is functioning as a unique “bridge” linking bench research and clinical practice. Dr. Yang has received over $12,000,000 in funding from US National Institutes of Health (NIH) and other funding agencies. As one of the pioneers, Dr. Yang has created several new concepts and technologies on medical imaging and interventional radiology in the world, including developments of intraluminal MR imaging and interventions, MRI-tracking of stem cells in vascular diseases, imaging of vascular gene therapy, and interventional molecular imaging.

Awards and Honors

Recent Publications

See all publications on Scopus

Identification of tumorigenicity-associated genes in osteosarcoma cell lines based on bioinformatic analysis and experimental validation
Jiang S., Zhou F., Zhang Y., Zhou W., Zhu L., Zhang M., Luo J., Ma R., Xu X., Zhu J., Dong X., Zhang S., Fang J., Sun J., Yang X.
Journal of Cancer. 2020 Jan:3623-3633

Molecular imaging-monitored radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus-thymidine kinase gene therapy for rat orthotopic ovarian cancer
Li Y., Zhao S., Zhang F., Jin G., Zhou Y., Li P., Shin D., Yang X.
International Journal of Hyperthermia. 2020 Jan:101-109

WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling
Jiang S., Zhang M., Zhang Y., Zhou W., Zhu T., Ruan Q., Chen H., Fang J., Zhou F., Sun J., Yang X.
Cell Communication and Signaling. 2019 Aug

Characteristics of a novel cell line ZJU-0430 established from human gallbladder carcinoma
Zhou F., Zhang Y., Sun J., Yang X.
Cancer Cell International. 2019 Jul

Scatter correction for a clinical cone-beam CT system using an optimized stationary beam blocker in a single scan
Liang X., Jiang Y., Zhao W., Zhang Z., Luo C., Xiong J., Yu S., Yang X., Sun J., Zhou Q., Niu T., Xie Y.
Medical Physics. 2019 Jan

Association between eosinophilic leukocyte count and hematoma expansion in acute spontaneous intracerebral hemorrhage
Chen Q., Liu J., Xu H., He W., Li Y., Jiao L., Xiang Y., Zhan C., Chen J., Yang X., Huang S., Yang Y.
Frontiers in Neurology. 2019 Jan

Establishment and Characterization of Two Novel Cholangiocarcinoma Cell Lines
Zhang Y., Luo J., Dong X., Yang F., Zhang M., Zhao J., Wang Q., Zhou F., Sun J., Yang X.
Annals of Surgical Oncology. 2019 Jan

Orthotopic hepatocellular carcinoma: molecular imaging-monitored intratumoral hyperthermia-enhanced direct oncolytic virotherapy
Song J., Zhang F., Ji J., Chen M., Li Q., Weng Q., Gu S., Kogut M., Yang X.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2019 Jan:344-350

Establishment and characterization of three stable Basal/HER2-positive breast cancer cell lines derived from Chinese breast carcinoma with identical missense mutations in the DNA-binding domain of TP53
Zhou F., Zhang Y., Xu X., Luo J., Yang F., Wang L., Xie S., Sun J., Yang X.
Cancer Cell International. 2018 Aug

Non–Small-Cell lung cancer: Feasibility of intratumoral radiofrequency hyperthermia–enhanced herpes simplex virus thymidine kinase gene therapy
Ji J., Weng Q., Zhang F., Xiong F., Jin Y., Hui J., Song J., Gao J., Chen M., Li Q., Shin D., Yang X.
Radiology. 2018 Aug:612-620